文献速递胃肠外科围术期管理与 ERAS

结直肠吻合口漏对长期肿瘤学结局的影响:荷兰全国人群回顾性研究

Long-Term Oncological Outcomes After Colorectal Anastomotic Leakage: A Retrospective Dutch Population-based Study.
PubMed 文献 · Ann Surg · 2022-08-05

该研究基于荷兰癌症登记数据库(2008-2018年),纳入接受一期吻合切除的I-IV期结肠癌(CC)和直肠癌(RC)患者,分析吻合口漏(AL)对5年相对生存、无病生存(DFS)和复发的影响。结果显示AL对CC和RC的生存影响呈分期依赖的负向作用,但与疾病复发无独立关联。

要点

  • AL对结肠癌和直肠癌的5年相对生存影响呈分期依赖,II-III期结肠癌及III-IV期直肠癌死亡风险显著增高。
  • AL与结肠癌DFS显著降低相关,但与结直肠癌术后疾病复发无独立关联。
  • 所有分析仅纳入术后存活90天以上的患者。

核心结论

  • AL对结肠癌和直肠癌的长期生存均有分期依赖的负向影响,但与疾病复发无独立关联。

研究设计与样本

  • 回顾性荷兰全国人群研究,数据来自荷兰癌症登记(2008-2018年),纳入I-IV期结肠癌和直肠癌接受一期吻合切除的患者,分析仅限术后存活90天以上者。

主要发现

  • 结肠癌吻合口漏组与无漏组5年相对生存率分别为:I期95% vs 100%,II期89% vs 94%,III期66% vs 76%,IV期28% vs 25%。
  • 直肠癌吻合口漏组与无漏组5年相对生存率分别为:I期97% vs 101%,II期90% vs 95%,III期74% vs 83%,IV期32% vs 41%。
  • AL与II期和III期结肠癌患者死亡相对超额风险显著升高相关,也与III期和IV期直肠癌患者死亡相对超额风险显著升高相关。
  • 结肠癌伴AL患者DFS显著降低,但结直肠癌术后疾病复发与AL无独立关联。

临床怎么用

  • 结直肠癌术后发生吻合口漏的患者应关注长期肿瘤学结局,尤其II-III期结肠癌和III-IV期直肠癌患者。
  • AL病史可作为生存随访风险分层的参考因素,但不提示需针对复发采取额外干预。

局限性

  • 回顾性研究设计,仅纳入术后存活90天以上的患者,DFS和复发分析仅限2015年手术的I-III期患者子集。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim was to evaluate the impact of anastomotic leak (AL) after colon cancer (CC) and rectal cancer (RC) surgery on 5-year relative survival, disease-free survival (DFS), and disease recurrence. BACKGROUND: AL after CC and RC resection is a severe postoperative complication with conflicting evidence whether it deteriorates long-term outcomes. METHODS: Patients with stage I to IV CC and RC who underwent resection with primary anastomosis were included from the Netherlands Cancer Registry (2008-2018). Relative survival, measured from day of resection, and multivariable relative excess risks (RERs) were analyzed. DFS and recurrence were evaluated in a subset with stage I to III patients operated in 2015. All analyses were performed with patients who survived 90 days postoperatively. RESULTS: A total of 65,299 CC and 22,855 RC patients were included. Five-year relative survival after CC resection with and without AL was 95% versus 100%, 89% versus 94%, 66% versus 76%, and 28% versus 25% for stage I to IV disease. AL was associated with a significantly higher RER for death in stage II and III CC patients. Stage-specific 5-year relative survival in RC patients with and without AL was 97% versus 101%, 90% versus 95%, 74% versus 83%, and 32% versus 41%. AL was associated with a significantly higher RER for death in stage III and IV RC patients. DFS was significantly lower in CC patients with AL, but disease recurrence was not associated with AL after colorectal cancer resection. CONCLUSION: AL has a stage-dependent negative impact on survival in both CC and RC, but no independent association with disease recurrence.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Arron MNN, Greijdanus NG, Bastiaans S, et al. Long-Term Oncological Outcomes After Colorectal Anastomotic Leakage: A Retrospective Dutch Population-based Study. Ann Surg. 2022. PMID: 35930021. doi:10.1097/SLA.0000000000005647

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。